Role for Artificial Intelligence in the Detection of Immune-Related Adverse Events.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39356977.
- Also identified by DOI 10.1200/JCO-24-01570 and PMC identifier 12172021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the article that accompanies this editorial, Sun and colleagues utilized large language models (LLMs) to detect immune-related adverse events (irAEs) from electronic health records and demonstrated that LLMs had higher sensitivity than ICD codes alone (94.7% vs 68.7% respectively) and similar specificity, requiring a fraction of the time compared to manual adjudication. This research represents a significant step in enhancing the efficiency of our efforts to better understand irAEs by leveraging data in the electronic medical records from patients treated with immune checkpoint inhibitors over the last 15 years to better predict these toxicities, with the goal of minimizing or mitigating them entirely.